Search Results - "Kaldonska, Maria"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers by Gawrońska-Szklarz, Barbara, Adamiak-Giera, Urszula, Wyska, Elżbieta, Kurzawski, Mateusz, Gornik, Wanda, Kaldonska, Maria, Drozdzik, Marek

    Published in European journal of clinical pharmacology (01-09-2012)
    “…Objectives Pantoprazole is metabolized by cytochrome P450 2 C19, which shows genetic polymorphism. The effect of CYP2C19 polymorphism on single-dose…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease by Adamiak, Urszula, Kaldonska, Maria, Klodowska-Duda, Gabriela, Wyska, Elzbieta, Safranow, Krzysztof, Bialecka, Monika, Gawronska-Szklarz, Barbara

    Published in Clinical neuropharmacology (01-05-2010)
    “…The aims of the present study were to investigate the pharmacokinetic and pharmacodynamic (pk/pd) relationship of levodopa (l-dopa) in patients with advanced…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Assessment of liver function in children with acute lymphoblastic leukemia in remission by Mokrzycka, Małgorzata, Pawlik, Andrzej, Kałdońska, Maria, Millo, Barbara

    “…Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children. Antineoplastic treatment alone or with coexisting chronic viral hepatitis…”
    Get more information
    Journal Article